. 2023 May 23;12(6):1487–1504. doi: 10.1007/s40121-023-00802-4
© Pfizer Inc., Koen B. Pouwels, Maarten Postma, Louis Bont 2023
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1.
PRISMA flow diagram illustrating the study selection process